26 resources
By Version
By Authority
By Realm
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
|---|---|---|---|---|---|---|---|---|---|
| de.medizininformatikinitiative.kerndatensatz.biobank | R4 | Substance | Profile - Substance - Additiv | active | |||||
| hl7.fhir.us.breastcancer | R3 | cimi-entity-Substance | BC Substance Profile | draft | 2018-08 | us | hl7 | ||
| test.no.basis | R4 | no-basis-Substance | no-basis-Substance | active | 2019-07 | ||||
| hl7.fhir.it.lab-report | R4 | substance-additive-specimen-it-lab | Substance (specimen additive) - Lab Report | trial-use | 1 | 2024-03 | it | hl7 | |
| rki.demis.igs | R4 | AdapterSubstance | Adapter | active | 2024-10 | de | |||
| rki.demis.igs | R4 | PrimerSubstance | Primer-Scheme | active | 2024-10 | de | |||
| hl7.fhir.uv.crmi | R4 | crmi-shareablesubstance | CRMI Shareable Substance | trial-use | 2 | cds | 2025-08 | uv | hl7 |
| il.core.fhir.r4 | R4 | il-core-substance | ILCore Substance Profile | draft | 0 | il | national | ||
| il.core.fhir.r4.2023 | R4 | il-core-substance | ILCore Substance Profile | draft | 2023-05 | national | |||
| silfhirprofileig | R5 | sghi-substance | SGHI Substance | draft | 2025-07 | ||||
| hl7.fhir.us.qicore | R4 | qicore-substance | QICore Substance | trial-use | 4 | cqi | 2018-08 | us | hl7 |
| hl7.fhir.eu.imaging-r5 | R5 | Report-EuSubstance | Report obligations for EuSubstance | draft | 2025-08 | eu | hl7 | ||
| hl7.fhir.uv.crmi | R4 | crmi-substancedefinition | CRMI SubstanceDefinition | trial-use | 1 | cds | 2025-08 | uv | hl7 |
| il.hdp.fhir.r4 | R4 | il-hdp-substance | ILHDP Substance | draft | |||||
| hl7.fhir.uv.crmi | R4 | crmi-publishablesubstance | CRMI Publishable Substance | trial-use | 2 | cds | 2020-12 | uv | hl7 |
| nictiz.fhir.nl.stu3.zib2017 | R3 | zib-LaboratoryTestResult-Substance | HCIM LaboratoryTestResult Substance | active | nl | hl7 | |||
| hl7.fhir.uv.pharm-quality | R5 | Substance-drug-pq | Substance - Drug PQ | active | brr | 2024-05 | uv | hl7 | |
| hl7.fhir.au.base | R4 | au-substance | AU Base Substance | trial-use | 1 | 2025-06 | au | hl7 | |
| hl7.fhir.uv.lab-report | R4 | Substance-additive-uv-lab | Substance: Specimen Additive Substance | trial-use | oo | 2025-01 | uv | hl7 | |
| hl7.fhir.cz.core | R4 | Substance-additive-cz | Substance: Specimen Additive Substance (CZ) | draft | 2025-08 | cz | hl7 | ||
| hl7.fhir.eu.laboratory | R4 | Substance-additive-eu-lab | Substance: Specimen Additive Substance | draft | 2025-07 | eu | hl7 | ||
| ch.fhir.ig.ch-lab-report | R4 | ch-lab-specimen-additive-substance | CH LAB-Report Additive Substance | active | 2025-05 | ch | hl7 | ||
| hl7.eu.fhir.idea4rc | R4 | Substance-otherTreatment-eu-i4rc | Substance : Other Treatment | draft | 2025-07 | eu | hl7 | ||
| sfm.130323 | R4 | sfm-Excipient | SfmExcipient | active | 2021-05 | ||||
| sfm.130323 | R4 | sfm-Substance | sfm-Substance | active | 2021-05 | ||||
| tw.gov.mohw.nhi.pas | R4 | Substance-twpas | 放射治療總劑量-Substance TWPAS | active | 2025-08 | tw | national |
FHIR